Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study

OBJECTIVE: To explore the glucagon-like peptide-1 analogue liraglutide in the hospital setting in patients with type 2 diabetes mellitus (T2DM) and acute coronary syndrome and to evaluate the safety and efficacy and its impact on hospitalization and short-term glycemic variability (GV). METHODS: A 1...

Descripción completa

Detalles Bibliográficos
Autores principales: del Olmo-García, Maria Isabel, Hervás Marín, David, Caudet Esteban, Jana, Ballesteros Martin-Portugués, Antonio, Cerveró Rubio, Alba, Arnau Vives, Miguel Angel, Catalá Gregori, Ana, Penalba Martínez, Maite, Merino-Torres, Juan Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309403/
https://www.ncbi.nlm.nih.gov/pubmed/32567433
http://dx.doi.org/10.1177/0300060520926063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309403/
https://www.ncbi.nlm.nih.gov/pubmed/32567433
http://dx.doi.org/10.1177/0300060520926063

Ejemplares similares